Sustained drug release by contact lenses for glaucoma treatment - A review

Journal of Controlled Release

Volumn 202, Issue , 2015, Pages 76-82

  Carvalho, I M ^a   Marques, C S ^a   Oliveira, R S ^b   Coelho, P B ^b   Costa, P C ^a   Ferreira, D C ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

Author keywords

Contact lenses; Glaucoma; Nanoparticles; Ocular delivery; Ophthalmic

Indexed keywords

CONTACT LENSES; DISEASES; DRUG PRODUCTS; INDIUM COMPOUNDS; NANOPARTICLES; OPHTHALMOLOGY; TARGETED DRUG DELIVERY;

CHRONIC DISEASE; GLAUCOMA; OCULAR DELIVERY; OCULAR DISEASE; OPHTHALMIC; RESIDENCE TIME; SUSTAINED DRUG RELEASE; TOPICAL TREATMENTS;

CONTROLLED DRUG DELIVERY;

AGENTS ACTING ON THE EYE; ANTIGLAUCOMA AGENT; LIPID; NANOPARTICLE; DELAYED RELEASE FORMULATION;

ARTICLE; CHRONIC DISEASE; CONTACT LENS; DRUG RELEASE; EYE DISEASE; GLAUCOMA; HUMAN; MOLECULAR IMPRINTING; POLYMERIZATION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; ADMINISTRATION AND DOSAGE; ANIMAL; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; THERAPEUTIC USE;

ANIMALS; CONTACT LENSES; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; GLAUCOMA; HUMANS;

EID: 84922575853     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.01.023     Document Type: Review

References (99)

1. C.-C. Peng, M.T. Burke, B.E. Carbia, C. Plummer, and A. Chauhan Extended drug delivery by contact lenses for glaucoma therapy J. Control. Release 162 1 2012 152 158 10.1016/j.jconrel.2012.06.017
2. P.M. Hughes, O. Olejnik, J.-E. Chang-Lin, and C.G. Wilson Topical and systemic drug delivery to the posterior segments Adv. Drug Deliv. Rev. 57 14 2005 2010 2032 10.1016/j.addr.2005.09.004
3. T. Velpandian Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies Expert Opin. Drug Deliv. 6 3 2009 255 270 10.1517/17425240902798119
4. U.B. Kompella, R.S. Kadam, and V.H.L. Lee Recent advances in ophthalmic drug delivery Ther. Deliv. 1 3 2010 435 456 10.4155/TDE.10.40
5. V.R. Kearns, and R.L. Williams Drug delivery systems for the eye Expert Rev. Med. Devices 6 3 2009 277 290 10.1586/erd.09.4
6. R. Gaudana, H.K. Ananthula, A. Parenky, and A.K. Mitra Ocular drug delivery AAPS J. 12 3 2010 348 360 10.1208/s12248-010-9183-3
7. S.C. Patel, and G.L. Spaeth Compliance in patients prescribed eyedrops for glaucoma Ophthalmic Surg. 26 3 1995 233 236
8. J.L. Stone, A.L. Robin, G.D. Novack, D.W. Covert, and G.D. Cagle An objective evaluation of eyedrop instillation in patients with glaucoma Arch. Ophthalmol. 127 6 2009 732 736 10.1001/archophthalmol.2009.96
9. N.M. Davies, S.J. Farr, J. Hadgraft, and I.W. Kellaway Evaluation of mucoadhesive polymers in ocular drug delivery. II. Polymer-coated vesicles Pharm. Res. 9 9 1992 1137 1144 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/1409394. Accessed September 13, 2014)
10. S. Burgalassi, P. Chetoni, D. Monti, and M.F. Saettone Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines Toxicol. Lett. 122 1 2001 1 8 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/11397552. Accessed June 18, 2014)
11. A. Ludwig The use of mucoadhesive polymers in ocular drug delivery Adv. Drug Deliv. Rev. 57 11 2005 1595 1639 10.1016/j.addr.2005.07.005
12. A.S. Mundada, and J.G. Avari In situ gelling polymers in ocular drug delivery systems: a review Crit. Rev. Ther. Drug Carrier Syst. 26 1 2009 85 118 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/19496748. Accessed June 18, 2014)
13. M.M. Ibrahim, A.-E.H. Abd-Elgawad, O. a Soliman, and M.M. Jablonski Novel topical ophthalmic formulations for management of glaucoma Pharm. Res. 30 11 2013 2818 2831 10.1007/s11095-013-1109-1
14. M.R. Sawusch, T.P. O'Brien, J.D. Dick, and J.D. Gottsch Use of collagen corneal shields in the treatment of bacterial keratitis Am J. Ophthalmol. 106 3 1988 279 281 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/3138912. Accessed June 18, 2014)
15. A. Zimmer, J. Kreuter, and J.R. Robinson Studies on the transport pathway of PBCA nanoparticles in ocular tissues J. Microencapsul. 8 4 1991 497 504 10.3109/02652049109021873
16. R.C. Nagarwal, S. Kant, P.N. Singh, P. Maiti, and J.K. Pandit Polymeric nanoparticulate system: a potential approach for ocular drug delivery J. Control. Release 136 1 2009 2 13 10.1016/j.jconrel.2008.12.018
17. R.M. Mainardes, M.C.C. Urban, P.O. Cinto,et al., Colloidal carriers for ophthalmic drug delivery Curr. Drug Targets 6 3 2005 363 371 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/15857294. Accessed June 18, 2014)
18. U.L. Patel, N.P. Chotai, and C.D. Nagda Preparation and evaluation of ocular inserts for controlled delivery of gatifloxacin sesquehydrate Int. J. Pharm. Sci. 1 2 2009 342 352
19. U.L. Patel, N.P. Chotai, and C.D. Nagda Design and evaluation of polymeric ocular drug delivery system for controlled delivery of moxifloxacin hydrochloride: in vitro and in vivo evaluation Acta Pharm. Sci. 52 1 2010 523 535
20. N. Li, C.-Y. Zhuang, M. Wang, C.-G. Sui, and W.-S. Pan Low molecular weight chitosan-coated liposomes for ocular drug delivery: in vitro and in vivo studies Drug Deliv. 19 1 2012 28 35 10.3109/10717544.2011.621994
21. N.S. Elbialy, B.M. Abdol-Azim, M.W. Shafaa, L.H. El Shazly, A.H. El Shazly, and W.A. Khalil Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment J. Biomed. Nanotechnol. 9 12 2013 2105 2116 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/24266264. Accessed June 18, 2014)
22. H. Sasaki, K. Karasawa, K. Hironaka, K. Tahara, Y. Tozuka, and H. Takeuchi Retinal drug delivery using eyedrop preparations of poly-l-lysine-modified liposomes Eur. J. Pharm. Biopharm. 83 3 2013 364 369 10.1016/j.ejpb.2012.10.014
23. N.N. Rajendran, R. Natrajan, R. Kumar, and S. Selvaraj Acyclovir-loaded chitosan nanoparticles for ocular delivery Asian J. Pharm. 4 4 2010 220 226
24. P. Bhagav, V. Trivedi, D. Shah, and S. Chandran Sustained release ocular inserts of brimonidine tartrate for better treatment in open-angle glaucoma Drug Deliv. Transl. Res. 1 2 2011 161 174 10.1007/s13346-011-0018-2
25. H. Gupta, and M. Aqil Contact lenses in ocular therapeutics Drug Discov. Today 17 9-10 2012 522 527 10.1016/j.drudis.2012.01.014
26. C. Shah, C.V.S. Raj, and G.N. Foulks The evolution in therapeutic contact lenses Ophthalmol. Clin. North Am. 16 1 2003 95 101 (vii. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12683252. Accessed June 18, 2014)
27. P.C. Nicolson, and J. Vogt Soft contact lens polymers: an evolution Biomaterials 22 24 2001 3273 3283 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/11700799. Accessed June 18, 2014)
28. U. FDA http://www.fda.gov/downloads/MedicalDevices/.../ucm080960.pdf 2014 (No Title, Available at:)
29. C. González-Chomón, A. Concheiro, and C. Alvarez-Lorenzo Soft contact lenses for controlled ocular delivery: 50 years in the making Ther. Deliv. 4 9 2013 1141 1161 10.4155/tde.13.81
30. P.C. Donshik Extended wear contact lenses Ophthalmol. Clin. North Am. 16 1 2003 79 87 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/12683250. Accessed June 18, 2014)
31. F. Stapleton, S. Stretton, E. Papas, C. Skotnitsky, and D.F. Sweeney Silicone hydrogel contact lenses and the ocular surface Ocul. Surf. 4 1 2006 24 43 10.1016/S1542-0124(12)70262-8
32. L.B. Morgan A new drug delivery system for the eye IMS Ind. Med. Surg. 40 6 1971 11 13 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/5285990. Accessed December 16, 2014)
33. D.M. Maurice Prolonged release systems and topically applied drugs Sight Sav. Rev. 42 1 1972 42 50 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/5033186. Accessed December 16, 2014)
34. Y.T. Maddox, and H.N. Bernstein An evaluation of the bionite hydrophilic contact lens for use in a drug delivery system Ann. Ophthalmol. 4 9 1972 789 790 (passim. Available at: http://www.ncbi.nlm.nih.gov/pubmed/5056922. Accessed December 16, 2014)
35. L.C. Bengani, K.-H. Hsu, S. Gause, and A. Chauhan Contact lenses as a platform for ocular drug delivery Expert Opin. Drug Deliv. 10 11 2013 1483 1496 10.1517/17425247.2013.821462
36. J.V. Forrester, A.D. Dick, P.G. McMenamin, and W.R. Lee The Eye: Basic Sciences in Practice 2002 WB Saunders Philadelphia
37. J.L. Creech, A. Chauhan, and C.J. Radke Dispersive mixing in the posterior tear film under a soft contact lens Ind. Eng. Chem. Res. 40 14 2001 3015 3026 10.1021/ie000596z
38. C.-C. Li, and A. Chauhan Modeling ophthalmic drug delivery by soaked contact lenses Ind. Eng. Chem. Res. 45 10 2006 3718 3734 10.1021/ie0507934
39. A.R. Gasset, Y. Ishii, H.E. Kaufman, and T. Miller Cytotoxicity of ophthalmic preservatives Am J. Ophthalmol. 78 1 1974 98 105 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/4835060. Accessed June 18, 2014)
40. G.J. Berdy, M.B. Abelson, L.M. Smith, and M.A. George Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects Arch. Ophthalmol. 110 4 1992 528 532 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/1562263. Accessed June 18, 2014)
41. H.A. Quigley, and A.T. Broman The number of people with glaucoma worldwide in 2010 and 2020 Br. J. Ophthalmol. 90 3 2006 262 267 10.1136/bjo.2005.081224
42. S. Blomdahl, B.M. Calissendorff, B. Tengroth, and O. Wallin Blindness in glaucoma patients Acta Ophthalmol. Scand. 75 5 1997 589 591 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/9469562. Accessed June 18, 2014)
43. R.D. Fechtner, and A.S. Khouri Evolving global risk assessment of ocular hypertension to glaucoma Curr. Opin. Ophthalmol. 18 2 2007 104 109 10.1097/ICU.0b013e32808373a2
44. D.A. Lee, and E.J. Higginbotham Glaucoma and its treatment: a review Am. J. Health Syst. Pharm. 62 7 2005 691 699 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/15790795. Accessed June 18, 2014)
45. B. Chae, T. Cakiner-Egilmez, and M. Desai Glaucoma medications Insight 38 1 2013 5 9 (quiz 10. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23505792. Accessed June 18, 2014)
46. A.P. Rotchford, and K.M. Murphy Compliance with timolol treatment in glaucoma Eye (Lond.) 12 Pt 2 1998 234 236 10.1038/eye.1998.56
47. D.S. Friedman, B. Nordstrom, E. Mozaffari, and H.a. Quigley Glaucoma management among individuals enrolled in a single comprehensive insurance plan Ophthalmology 112 9 2005 1500 1504 10.1016/j.ophtha.2005.02.030
48. M.M. Hermann, A.M. Bron, C.P. Creuzot-Garcher, and M. Diestelhorst Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring J. Glaucoma 20 8 2011 502 508 10.1097/IJG.0b013e3181f3eb4a
49. K. Pullum, and R. Buckley Therapeutic and ocular surface indications for scleral contact lenses Ocul. Surf. 5 1 2007 40 49 10.1016/S1542-0124(12)70051-4
50. C.C.S. Karlgard, N.S. Wong, L.W. Jones, and C. Moresoli In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials Int. J. Pharm. 257 1-2 2003 141 151 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/12711169. Accessed June 18, 2014)
51. A. Hui, A. Boone, and L. Jones Uptake and release of ciprofloxacin-HCl from conventional and silicone hydrogel contact lens materials Eye Contact Lens 34 5 2008 266 271 10.1097/ICL.0b013e3181812ba2
52. A. Boone, A. Hui, and L. Jones Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses Eye Contact Lens 35 5 2009 260 267 10.1097/ICL.0b013e3181b26c49
53. C.L. Schultz, T.R. Poling, and J.O. Mint A medical device/drug delivery system for treatment of glaucoma Clin. Exp. Optom. 92 4 2009 343 348 10.1111/j.1444-0938.2009.00370.x
54. A. Soluri, A. Hui, and L. Jones Delivery of ketotifen fumarate by commercial contact lens materials Optom. Vis. Sci. 89 8 2012 1140 1149 10.1097/OPX.0b013e3182639dc8
55. D.P. North Treatment of acute glaucoma Can. Med. Assoc. J. 105 6 1971 561- (Available at: http://www.cmaj.ca/content/105/6/561.citation. Accessed June 18, 2014)
56. H.E. Kaufman, M.H. Uotila, and A.R. Gasset The medical uses of soft contact lenses Trans. Am. Acad. Ophthalmol. Otolaryngol. 75 1971 361 373
57. C.F. Asseff, R.L. Weisman, S.M. Podos, and B. Becker Ocular penetration of pilocarpine in primates Am. J. Ophthalmol. 75 2 1973 212 215 10.1016/0002-9394(73)91015-5
58. J.S. Hillman Management of acute glaucoma with pilocarpine-soaked hydrophilic lens Br. J. Ophthalmol. 58 7 1974 674 679 (Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1214985&tool=pmcentrez&rendertype=abstract. Accessed June 18, 2014)
59. R.M. Ramer, and A.R. Gasset Ocular penetration of pilocarpine: the effect on concentration on the ocular penetration of pilocarpine Ann. Ophthalmol. 6 11 1974 1160 1162 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/4429321. Accessed June 18, 2014)
60. J.S. Hillman, J.B. Marsters, and A. Broad Pilocarpine delivery by hydrophilic lens in the management of acute glaucoma Trans. Ophthalmol. Soc. U. K. 95 1 1975 79 84 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/1064215. Accessed June 18, 2014)
61. M. Ruben, and R. Watkins Pilocarpine dispensation for the soft hydrophilic contact lens Br. J. Ophthalmol. 59 8 1975 455 458 (Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1017392&tool=pmcentrez&rendertype=abstract. Accessed June 18, 2014)
62. V.J. Marmion, and S. Yurdakul Pilocarpine administration by contact lens Trans. Ophthalmol. Soc. U. K. 97 1 1977 162 163 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/271388. Accessed June 18, 2014)
63. C.-C. Peng, J. Kim, and A. Chauhan Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers Biomaterials 31 14 2010 4032 4047 10.1016/j.biomaterials.2010.01.113
64. R.E. Marquis, and J.T. Whitson Management of glaucoma: focus on pharmacological therapy Drugs Aging 22 1 2005 1 21 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/15663346. Accessed June 18, 2014)
65. F.T. Fraunfelder, and S.M. Meyer Systemic side effects from ophthalmic timolol and their prevention J. Ocul. Pharmacol. 3 2 1987 177 184 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/3503912. Accessed June 18, 2014)
66. C.-C. Peng, A. Ben-Shlomo, E.O. Mackay, C.E. Plummer, and A. Chauhan Drug delivery by contact lens in spontaneously glaucomatous dogs Curr. Eye Res. 37 3 2012 204 211 10.3109/02713683.2011.630154
67. M. Nagata, M. Kojima, and K. Sasaki Effect of vitamin E eye drops on naphthalene-induced cataract in rats J. Ocul. Pharmacol. Ther. 15 4 1999 345 350 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/10463873. Accessed June 18, 2014)
68. K. Bilgihan, U. Adiguzel, C. Sezer, G. Akyol, and B. Hasanreisoglu Effects of topical vitamin E on keratocyte apoptosis after traditional photorefractive keratectomy Ophthalmologica 215 3 2001 192 196 10.1159/000050857
69. T. Yilmaz, O. Aydemir, I.H. Ozercan, and B. Ustundaʇ Effects of vitamin e, pentoxifylline and aprotinin on light-induced retinal injury Ophthalmologica 221 3 2007 159 166 10.1159/000099295
70. A. Tieppo, C.J. White, A.C. Paine, M.L. Voyles, M.K. McBride, and M.E. Byrne Sustained in vivo release from imprinted therapeutic contact lenses J. Control. Release 157 3 2012 391 397 10.1016/j.jconrel.2011.09.087
71. B. Malaekeh-Nikouei, F.A. Ghaeni, V.S. Motamedshariaty, and S.A. Mohajeri Controlled release of prednisolone acetate from molecularly imprinted hydrogel contact lenses J. Appl. Polym. Sci. 126 1 2012 387 394 10.1002/app.36625
72. H. Hiratani, Y. Mizutani, and C. Alvarez-Lorenzo Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities Macromol. Biosci. 5 8 2005 728 733 10.1002/mabi.200500065
73. S. Venkatesh, J. Saha, S. Pass, and M.E. Byrne Transport and structural analysis of molecular imprinted hydrogels for controlled drug delivery Eur. J. Pharm. Biopharm. 69 3 2008 852 860 10.1016/j.ejpb.2008.01.036
74. M.E. Byrne, and V. Salian Molecular imprinting within hydrogels II: progress and analysis of the field Int. J. Pharm. 364 2 2008 188 212 10.1016/j.ijpharm.2008.09.002
75. C.J. White, A. Tieppo, and M.E. Byrne Controlled drug release from contact lenses: a comprehensive review from 1965-present J. Drug Deliv. Sci. Technol. 21 5 2011 369 384 10.1016/S1773-2247(11)50062-0
76. C. Alvarez-Lorenzo, F. Yañez, R. Barreiro-Iglesias, and A. Concheiro Imprinted soft contact lenses as norfloxacin delivery systems J. Control. Release 113 3 2006 236 244 10.1016/j.jconrel.2006.05.003
77. A.D. Vaughan, J.B. Zhang, and M.E. Byrne Enhancing therapeutic loading and delaying transport via molecular imprinting and living/controlled polymerization AICHE J. 56 1 2010 268 279 10.1002/aic.11949
78. M. Ali, and M.E. Byrne Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses Pharm. Res. 26 3 2009 714 726 10.1007/s11095-008-9818-6
79. C.J. White, M.K. McBride, K.M. Pate, A. Tieppo, and M.E. Byrne Extended release of high molecular weight hydroxypropyl methylcellulose from molecularly imprinted, extended wear silicone hydrogel contact lenses Biomaterials 32 24 2011 5698 5705 10.1016/j.biomaterials.2011.04.044
80. J. Xu, X. Li, and F. Sun In vitro and in vivo evaluation of ketotifen fumarate-loaded silicone hydrogel contact lenses for ocular drug delivery Drug Deliv. 18 2 2011 150 158 10.3109/10717544.2010.522612
81. C. Alvarez-Lorenzo, H. Hiratani, J.L. Gómez-Amoza, R. Martínez-Pacheco, C. Souto, and A. Concheiro Soft contact lenses capable of sustained delivery of timolol J. Pharm. Sci. 91 10 2002 2182 2192 10.1002/jps.10209
82. H. Hiratani, A. Fujiwara, Y. Tamiya, Y. Mizutani, and C. Alvarez-Lorenzo Ocular release of timolol from molecularly imprinted soft contact lenses Biomaterials 26 11 2005 1293 1298 10.1016/j.biomaterials.2004.04.030
83. B. Malaekeh-Nikouei, S.A. Vahabzadeh, and S.A. Mohajeri Preparation of a molecularly imprinted soft contact lens as a new ocular drug delivery system for dorzolamide Curr. Drug Deliv. 10 3 2013 279 285 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/23360228. Accessed June 18, 2014)
84. D. Gulsen, and A. Chauhan Ophthalmic drug delivery through contact lenses Invest. Ophthalmol. Vis. Sci. 45 7 2004 2342 2347 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/15223815. Accessed June 18, 2014)
85. D. Gulsen, and A. Chauhan Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle Int. J. Pharm. 292 1-2 2005 95 117 10.1016/j.ijpharm.2004.11.033
86. C.-C. Li, M. Abrahamson, Y. Kapoor, and A. Chauhan Timolol transport from microemulsions trapped in HEMA gels J. Colloid Interface Sci. 315 1 2007 297 306 10.1016/j.jcis.2007.06.054
87. Y. Kapoor, and A. Chauhan Ophthalmic delivery of cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels Int. J. Pharm. 361 1-2 2008 222 229 10.1016/j.ijpharm.2008.05.028
88. H.D. Perry, E.D. Donnenfeld, A.J. Kanellopoulos, and G.A. Grossman Topical cyclosporin A in the management of postkeratoplasty glaucoma Cornea 16 3 1997 284 288 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/9143799. Accessed June 18, 2014)
89. Y. Kapoor, J.C. Thomas, G. Tan, V.T. John, and A. Chauhan Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs Biomaterials 30 5 2009 867 878 10.1016/j.biomaterials.2008.10.032
90. A. Danion, H. Brochu, Y. Martin, and P. Vermette Fabrication and characterization of contact lenses bearing surface-immobilized layers of intact liposomes J. Biomed. Mater. Res. A 82 1 2007 41 51 10.1002/jbm.a.31147
91. A. Danion, I. Arsenault, and P. Vermette Antibacterial activity of contact lenses bearing surface-immobilized layers of intact liposomes loaded with levofloxacin J. Pharm. Sci. 96 9 2007 2350 2363 10.1002/jps.20871
92. H.J. Jung, and A. Chauhan Ophthalmic drug release by contact lenses 7(3) 2012 1 3
93. H.J. Jung, M. Abou-Jaoude, B.E. Carbia, C. Plummer, and A. Chauhan Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses J. Control. Release 165 1 2013 82 89 10.1016/j.jconrel.2012.10.010
94. J.B. Ciolino, C.F. Stefanescu, and A.E. Ross In vivo performance of a drug-eluting contact lens to treat glaucoma for a month Biomaterials 35 1 2014 432 439 10.1016/j.biomaterials.2013.09.032
95. T. Loftsson, M. Másson, and M.E. Brewster Self-association of cyclodextrins and cyclodextrin complexes J. Pharm. Sci. 93 5 2004 1091 1099 10.1002/jps.20047
96. J.-F.R. Dos Santos, R. Couceiro, A. Concheiro, J.-J. Torres-Labandeira, and C. Alvarez-Lorenzo Poly(hydroxyethyl methacrylate-co-methacrylated-beta-cyclodextrin) hydrogels: synthesis, cytocompatibility, mechanical properties and drug loading/release properties Acta Biomater. 4 3 2008 745 755 10.1016/j.actbio.2007.12.008
97. J. Xu, X. Li, and F. Sun Cyclodextrin-containing hydrogels for contact lenses as a platform for drug incorporation and release Acta Biomater. 6 2 2010 486 493 10.1016/j.actbio.2009.07.021
98. R.X. Kang The intraocular pressure depressive effect of puerarin Zhonghua Yan Ke Za Zhi 29 6 1993 336 339 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/7912669. Accessed June 18, 2014)
99. M.J. García-Fernández, N. Tabary, and B. Martel Poly-(cyclo)dextrins as ethoxzolamide carriers in ophthalmic solutions and in contact lenses Carbohydr. Polym. 98 2 2013 1343 1352 10.1016/j.carbpol.2013.08.003